FEATURED
Presenting Groundbreaking ANALYSES at the Menopause Society 2024 Annual Meeting
Menopause Society | 2024 Annual Meeting
Promoting impactful research to improve sleep quality
Sleep Number will present new research at the Menopause Society's 2024 annual meeting, September 10th through the 14th. Findings will discuss the association between sleep quality and menopausal symptoms leveraging smart bed data collected in a real-world, home environment, and the Smart Sleeper Panel, a cohort of hundreds of thousands of Sleep Number smart bed sleepers who’ve opted to participate in sleep science research. These studies further demonstrate the research capabilities of Sleep Number smart beds to understand the impact of sleep on health and advance sleep science without an in-lab sleep study.
Association between sleep quality and severity of menopausal symptoms Download Presentation Women transitioning to menopause and post-menopause are more likely to report sleep difficulties compared to pre-menopausal women. To quantify the association between self-reported severity of menopause symptoms and objective sleep metrics, we leveraged objective sleep data collected by the Sleep Number bed platform and survey data from the Sleep Number Sleep Science Panel. The data include demographic information, subjective reports on menopause symptoms, symptom severity, date of symptom onset, and symptom alleviation treatment. The dataset for analysis included 311 survey respondents that reported menopause symptoms and approximate symptom-onset date. We found that sleep quality as revealed by the sleep IQ score is significantly lower for women reporting severe symptoms of menopause. The effect of pharmacological treatment to alleviate menopause symptoms resulted in a significant increase in restful sleep duration of ~20 minutes and an increase in time-domain heart rate variability (HRV) of ~20 milliseconds. The objective data collected by the Sleep Number platform reveals the decrease in sleep quality associated with menopause symptoms and can also detect the improvement in restful sleep and HRV associated with symptom-alleviation treatment.